• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Bull trend intact, S&P 500 absorbs mid-August -2-

    Bull trend intact, S&P 500 absorbs mid-August -2-

  2. UPDATE: Bull trend intact, S&P 500 absorbs -2-

    UPDATE: Bull trend intact, S&P 500 absorbs -2-

  3. UPDATE: Bull trend intact, S&P 500 absorbs mid-August plunge

    UPDATE: Bull trend intact, S&P 500 absorbs mid-August plunge

  4. UPDATE: Charting the S&P 500's grinding-higher breakout attempt, record territory under siege

    UPDATE: Charting the S&P 500's grinding-higher breakout attempt, record territory under siege

  5. UPDATE: Charting the S&P 500's grinding-higher -2-

    UPDATE: Charting the S&P 500's grinding-higher -2-

  6. Bull trend intact, charting the approach of -2-

    Bull trend intact, charting the approach of -2-

  7. Bull trend intact, charting the approach of Dow 22,000

    Bull trend intact, charting the approach of Dow 22,000

  8. UPDATE: Bull trend intact, charting the -2-

    UPDATE: Bull trend intact, charting the -2-

  9. UPDATE: Bull trend intact, charting the approach of Dow 22,000

    UPDATE: Bull trend intact, charting the approach of Dow 22,000

  10. Companion Diagnostics Market to Reach $6.5 Billion by 2022: Analysis by Technology, Indication, and End User - Research and Markets

    Companion Diagnostics Market to Reach $6.5 Billion by 2022: Analysis by Technology, Indication, and End User - Research and Markets

123

©2017 Morningstar Advisor. All right reserved.